Celldex Therapeutics (CLDX) Interest Expenses (2010 - 2013)
Celldex Therapeutics (CLDX) recorded Interest Expenses of $85,000 in Q4 2013, down 75.8% from $351,000 a year earlier but up 553.8% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Interest Expenses (2010 - 2013) Analysis & Trends
For FY2013, Celldex Therapeutics reported Interest Expenses of $927,000, down 41.2% from FY2012.
- Annual Interest Expenses has a four-year compound annual growth rate of 19.7% (FY2009 to FY2013).
- Across earlier years, Interest Expenses came in at $1.58 million in FY2012 (-12.2%), $1.8 million in FY2011 (+34.3%), $1.34 million in FY2010 (+195.8%) and $452,000 in FY2009.
- Quarterly Interest Expenses has ranged from $13,000 in Q3 2013 to $519,000 in Q2 2013 over the past five years.
- On a year-over-year basis, Interest Expenses rose in 1 of the last eight quarters, with an average decline of 27.9%.
- Peak year-over-year performance for Interest Expenses in the last five years was growth of 31.9% in Q3 2011, against a decline of 96.6% in Q3 2013 at the low end.
- Per Business Quant, the preceding three quarters came in at $13,000 (Q3 2013), $519,000 (Q2 2013) and $310,000 (Q1 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Celldex Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | 85,000.00 |
| Sep 30, 2013 | 13,000.00 |
| Jun 30, 2013 | 519,000.00 |
| Mar 31, 2013 | 310,000.00 |
| Dec 31, 2012 | 351,000.00 |
| Sep 30, 2012 | 381,000.00 |
| Jun 30, 2012 | 411,000.00 |
| Mar 31, 2012 | 433,000.00 |
| Dec 31, 2011 | 438,000.00 |
| Sep 30, 2011 | 438,000.00 |
| Jun 30, 2011 | 434,000.00 |
| Mar 31, 2011 | 485,000.00 |
| Dec 31, 2010 | 335,000.00 |
| Sep 30, 2010 | 332,000.00 |
| Jun 30, 2010 | 334,000.00 |
API Access
Celldex Therapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();